Summary: In 76 normal volunteers studied by positron emission tomography, with [I8P]fluorodeoxyglucose, CMRg1u was significantly lower in the elderly as com pared with young subjects and significantly higher in fe males relative to males. However, in 58 of these subjects who also had magnetic resonance imaging scans, age and gender were found to be unrelated to CMRgl U , when the effects of brain volume and brain atrophy on CMRglu were partialed out using covariate analyses. Individually, brain volume was found to have a significant effect on CMRgl U , explaining -17% of the variability in CMRglu measures and brain atrophy explaining -8% of the vari ance in CM�u. To gether these two measures accounted Because CBF and CMR g lu are closely linked to the functional activity of the brain (Des Rosiers et aI. , 1974; Sokoloff, 1978) , these parameters should be sensitive indices of brain dysfunction. In fact, global CMR g lu, when expressed in absolute units, is relatively insensitive to a variety of disease states that affect the functioning of the brain (Duara et aI.,
for -21% of the variance. Cerebrovascular risk factors in normal subjects were not found to affect mean CMRglu or the variability of CMRglu measures. In this study almost 80% of the variance in CMRglu could not be explained by any of the factors that had been considered. This implies a lack of sensitivity of absolute values of global CMRglu to the mild effects of brain dysfunction. Although some of the unexplained variance is probably methodological in origin, physiological factors that are difficult to quantify, such as the state of arousal, are likely to be contributory as well. Key Words: Cerebral glucose metabolism Aging-Gender-Brain volume-Brain atrophy-Vas cular disease.
1986; Mazziotta et aI., 1987) . This can largely be attributed to the variability of CMR g lu measure ments in normal and diseased individuals (Duara et aI., 1987) . Only when regional absolute values are normalized to absolute values of some reference brain region does the variability decrease to levels that allow separation of abnormal from normal sub jects (Duara et aI., 1986) . However, normalized values do not convey important information that is contained in absolute measures. In efforts to deter mine what factors influence the variability of CMR g lu and CBF, several investigators in the last three decades have examined age and cerebrovas cular risk factors. Dastur et al. (1963) , using the nitrous oxide inha lation technique (Kety and Schmidt, 1948) , found that CBF and oxygen metabolism were unchanged, whereas CMR g lu declined with age, in optimally healthy, normal subjects. However, many studies have used other methods to measure cerebral blood flow and metabolism. Divergent results have emerged (Frackowiak et aI., 1980; Kuhl et aI., 1982; de Leon et aI., 1984; Duara et aI., 1984) , except in the case of CBF, which almost invariably has been found to decline with age, even in the most healthy and rigidly screened subjects (Naritomi et aI., 1979; Melamed et aI., 1980; Butler et aI., 1983; Lebrun Grandie, 1983) .
Apart from aging and cerebrovascular risk factors, several other factors that may affect vari ability of CBF and CMRg\u in normal subjects should be considered. These include the sensory environment in which the studies are done (Maz ziotta and Phelps, 1985; Duara et aI., 1987) , gender effects (Devous et aI., 1986; , and effects of head size (Hatazawa et aI., 1987) . Because brain atrophy occurs to a variable extent in normal aging, this factor should also be consid ered, because it introduces an error in quantitation when positron emission tomography (PET) is used (Schlageter et aI., 1987) .
In this study the effects of the above-mentioned factors were studied in relation to the extent that they accounted for the explained variance in CMRglu values. The sensory environment in which the PET scans were conducted was held constant for all subjects, eliminating sensory stimulation as a confounding factor. Thus, we endeavored to esti mate the individual contributions of age, gender, brain size, brain atrophy, and cerebrovascular risk factors on the interindividual variance of CMRg\u in humans.
SUBJECTS AND METHODS

Subjects
Seventy-six healthy volunteers aged 21-84 years (mean age: 53.7 ± 19.0) were recruited by media an nouncements and word of mouth. They were screened for systemic, cardiovascular, renal, and endocrine dis orders by a medical history and physical examination, ECG, chest radiography, and routine laboratory screening as previously described (Duara et aI., 1983) . The subjects were classified into "risk-negative" and "risk-positive" groups for thromboembolic stroke and cerebrovascular disease. Risk factors included a history of hypertension with hypertension on examination (de fined as blood pressure in excess of 160/90 mm Hg on at least three separate occasions); hyperlipidemia defined as elevated serum cholesterol above 300 mg/dO; heart dis ease, indicated by history, symptoms of angina, or signs of cardiac dysrhythmia with ECG abnormalities; and dia betes mellitus, confirmed by presence of glucose intoler ance. Any subject who had at least one of the above risk factors was regarded as risk-positive. The results in the risk-positive group were compared with those in 35 age equivalent risk-negative subjects.
PET
All 76 subjects had PET scans. The age range was 21-84 years; 39 were men and 37 were women. [,sF]Fluorodeoxyglucose (FDG) was prepared by the cy clotron staff of the Mount Sinai Medical Center, using the nucleophilic reaction (Tewson, 1983) modified to produce multimillicurie doses (Vora et al., 1985) . [,sF]Fluoro deoxymannose contamination was not detectable using this synthetic method (Shiue et al., 1985) . Subjects ar rived 1 h before commencement of PET scanning (per formed between 11:00 a.m. and 4: 00 p.m.). SUbjects re mained fasting for a minimum period of 3 h before the study and had not smoked cigarettes or taken any medi cation, alcohol, coffee, or tea on the day of the study.
Thirty minutes before injection of FDG, two intrave nous catheters were introduced into a dorsal vein of each hand, through which normal saline was infused. One hand was heated in a lucite chamber and the ambient air temperature was maintained at -45°C. Arterialized venous blood samples were drawn at predetermined in tervals from this heated hand vein, during the course of the study, for the measurement of plasma concentration of radioactivity and glucose. Arterialization by this method was checked in the first 20 studies by measure ment of pOz levels. During this time it became apparent that the adequacy of arterialization could be effectively predicted by the shape of the plasma radioactivity curve, i.e., a peak occurring in -1 min followed by a steep de cline to <50% of the peak value within 5 min after injec tion of the tracer. Hence, this shape of the plasma radio activity curve was subsequently used as a measure of ad equate arterialization.
Ten minutes before injection of FDG, the subjects were required to lie supine in a quiet, darkened room, with eyes closed and covered by a blindfold. This condition was maintained until the end of the study. Thirty minutes after the injection of FDG, scanning was performed by a PETT V (Washington University, St. Louis, MO), seven slice camera (image resolution: 15 mm full width at half maximum in the axial plane), for a duration sufficient to obtain 1.5-2.0 x 106 counts in the slice with the highest activity (average time: 20 min).
Attenuation correction of the images was performed by means of an operator-drawn ellipse. Two concentric el lipses separated by 1.4 cm were used. The inner ellipse was used for positioning and was placed so as to coincide at the half maximum level with the shoulders of the transverse histograms of radioactivity concentration (coinciding with the outer edge of the brain). The outer ellipse roughly coincided with the scalp, and it was this ellipse that was used for attenuation correction.
Slices were assigned a level above the inferior orbito meatal (10M) line, parallel to the plane of scanning and using a standard brain atlas (Eycleshymer and Schoe maker, 1911) as described previously (Duara et aI., 1983) . Regions of interest were obtained by a computer program that automatically placed 8 x 8-mm size contiguous boxes over the entire cortex and peak subcortical gray matter structures. Positions of any of the boxes were ad justable by the operator who then selected one to four boxes to correspond to each of 67 regions (32 bilateral and 3 midline regions) as shown in the standard brain atlas. [This method of analysis corresponds to the method described in a previous publication (Duara et aI., 1983) , with the exception that boxes of a fixed size were projected on to the cortex and subcortical regions rather than free-hand outlining of regions of interest.]
Regional cerebral metabolic rates for glucose (rCMRglu) for gray matter structures were calculated using an operational equation (Hutchins et al., 1984) . Mean cerebral gray matter rate for glucose (xCMRglu) was calculated by obtaining a mean value for all gray matter boxes in the brain selected for regional analysis. Also, rCMRglu values, reflecting the mean value for all regions contained in the frontal, parietal, temporal, and occipital lobes and the basal ganglia/thalamus region, were calculated.
Brain size
Measurements of brain size were made in 58 subjects aged 21-81 years old (mean ± SD: 56.3 ± 17.5) who had magnetic resonance (MR) scans in addition to the PET scans. Twenty-nine were men and 29 were women. MR scans were done using a 2.0 T Siemens Magnetom (Iselin, NJ) superconductive magnet operating at 1.0 T, and a 25-cm-diameter head coil. The scans were made at a plane parallel to the 10M line (the same plane as the PET scans). Slice thickness was 10 mm, with 3-mm gaps be tween adjacent sections. Tr ansverse inversion recovery images (inversion time of 400 ms, repetition time of 2.1 s, and echo time of 35 ms) were used. The outline of the brain at the level of the foramen of Monro was traced. This level can be readily identified on PET images as well, and corresponds to the 45-mm level in the standard brain atlas used for region identification. Area measure ments were performed on this MR brain slice using a planimeter (Kuffer and Essor Co., 620005). The outline measured was the perimeter of the brain, excluding sulcal spaces. The area measurement was then converted into a volume measurement by raising the value to 3/2 power, which gave an estimated volume for the whole brain. (In fact, this measure was always an overestimate, because brain shape corresponds to something less than a sphere.)
Brain atrophy measurement
In the 58 subjects who had MR scans, a semiquantita tive estimation of brain atrophy was made. (Quantitative estimation of brain atrophy is possible using a computer program to identify gray matter, CSF, and white matter according to pixel intensity, on inversion-recovery images. However, in horizontal slices the error in the es timation of subarachnoid CSF volume is so great that a semiquantitative approach seemed justified.) The rater was blind to subject age and gender. In the case of cor tical atrophy, a score of 0-3 (representing increasing at rophy) was given for frontal, parietooccipital, and tem poral regions on each side (right and left). For ventricular enlargement, a score of 0-3 (representing increasing ven tricular size) was given for the anterior half, the posterior half, and the temporal horns of the lateral ventricles. The scoring was done by comparison of each scan to a set of standard scans representing each level of cortical atrophy and of ventricular enlargement. Summary scores for cor tical atrophy (maximum score: 18) and for ventricular en largement (maximum score: 18) were obtained by adding up the regional scores for both right and left sides. An overall score of brain atrophy was obtained by adding the summary scores for ventricular enlargement and cortical atrophy.
Statistical analysis
We were able to study 76 normal volunteers with PET scans. We have, therefore, presented the data on this full complement of subjects. However, we were able to ob tain MR scans on only 58 of these individuals. Hence, the analysis of the results was divided accordingly. Data were analyzed for three overlapping groups of subjects:
1. Seventy-six subjects who had PET scans were grouped according to gender (male versus female) and age (50 years and above versus below 50 years). xCMRglu was examined using age and gender as independent grouping functions in a one-way analysis of variance (AN OVA). Frontal, temporal, parietal, and occipital lobe CMRglu values were treated as dependent measures and examined in the context of a multivariate analysis of vari ance (MANOVA) approach. Univariate analyses were only examined after a significant multivariate F. Posthoc tests were conducted using the Student-Neuman-Keuls procedure.
2. Brain volume was examined with respect to its rela tionship with age, and with xCMRglu by Pearson product moment correlation coefficients, and with respect to gender, by Student's t test. Similarly, brain atrophy was examined by Pearson product moment correlations and t tests with respect to relationship with age, gender, and xCMRglu' Regional atrophy measures for frontal, parie tooccipital, and temporal areas were examined indepen dently with respect to their relationship with corre sponding regional CMRglu values. Subjects were grouped according to gender (male versus female) and age (50 years and above versus below 50 years). xCMRglu and regional CMRglu (rCMRglu) values for frontal, parietooc cipital, and temporal regions were examined using an analysis of covariance (ANCOVA). This approach per mitted examination of main effects and interactions for age and gender, while controlling for the effects of brain atrophy and brain volume.
3. To examine cerebrovascular risk factors, the xCMRglu and rCMRglu values of the cerebrovascular risk positive group were compared to those of an age-equiva lent risk-negative group. Corrections for multiple com parisons were conducted utilizing the Bonferroni proce dure.
The criterion for significance for all the above analyses was set at p = 0.05.
RESULTS
Results on 76 subjects who had PET studies Mean CMR gl u in all 76 subjects was 7. 2 ± 1. 8 mg' 100 g-I . min-I. Ta ble 1 gives xCMR gl u for the four groups, namely young men, elderly men, young women, and elderly women. When xCMR gl u was examined with age and gender as independent grouping factors, in a 2 x 2 ANOVA, the obtained results indicated the presence of a gender effect [F(1,72) = 7.3, p = 0. 009], with women having higher average values. There was also a significant age effect [F(1,72) = 6.3; p = 0.015], with young subjects having higher xCMR gl u values than elderly subjects. No age by gender interaction was ob tained [F(1,72) = 2. 1; p = 0.10]. To further ex- Results on 58 subjects who had PET and MR scans Estimated brain volume (Table 3) was signifi cantly different between men and women, being 2,032 ± 216 cm3 in men and 1,813 ± 200 cm3 in women (p = 0.001). Brain volume was not signifi cantly correlated with age in men (r = 0.11) or women (r = 0.12) or for the whole group. In con trast, brain volume was significantly correlated with xCMRglu in men (r = -0.37, p = 0.05) but not in women (r = -0.30, p = 0.11), although the trend was in the expected direction.
There was a strong relationship between age and brain atrophy (Table 4) . To tal brain atrophy was highly correlated with age (r = 0,81, p < 0.001), with older subjects evidencing greater atrophy. This effect was present in men and women i nde pendently, for measures of cortical atrophy and ventricular dilatation, and for all regional measures of cortical atrophy and ventricular dilatation. Total brain atrophy was significantly and negatively cor related with xCMRglu (r = -0.24, p = 0.03), and significant relationships between frontal and parie tooccipital atrophy and CMRglu for these! corre sponding regions were present, with those �ubjects who had greater atrophy evidencing lower meta bolic values. An ANCOVA was performed with xCMRglu as the dependent measure, gender and age group as the independent grouping factors, and brain volume and brain atrophy scores used as covariates. Before the covariates were entered into the equation, there was a significant effect for gender [F(l,54) Results on cerebrovascular risk-positive and risk-negative subjects
In 11 risk-positive subjects (mean age = 70.6 ± 9.7 years), all had hypertension, and in addition two had hyperlipidemia, two had heart disease (an gina pectoris and arrhythmia), and two had mild diabetes. xCMRglu values in these 11 subjects were then compared with those of 35 age-equivalent risk-negative subjects (mean age = 66.1 ± 8.5 years). CMRglu values for these subjects are shown in Ta ble 6. xCMRglu in the risk-positive group was 6.9 ± 1.5 mg . 100 g-I . min -I, and in the risk-neg ative group was 6.2 ± 1.3; the difference was non significant. Similar results were obtained when re gional values were examined, and when only men were included in the analyses. 70.6 ± 9.7 6.9 ± 1.5
6.5 ± 1.1
Risk-negative subjects 35 (17 men , 18 women)
66.1 ± 8.5 6.2 ± 1.3
6.4 ± 1.2 Q Mean cerebral metabolic rate for glucose in mg' 100 g-! . min-! ± SD.
DISCUSSION
Our results indicate that when brain atrophy and volume are not considered, mean cerebral glucose metabolism is lower in elderly than in young sub jects, and that this significant effect is related to frontal, parietal, and temporal reductions in CMRglu in the elderly. In addition, women have signifi cantly higher xCMRglu than men. However, when brain volume and brain atrophy are accounted for, the effects of age and gender no longer have any significant impact on xCMRglu , accounting together for < 1 % of the total variance in xCMRglu' On the other hand, brain volume individually accounts for -17% and brain atrophy accounts for -8% of the total variance in xCMRglu' The presence of cere brovascular risk factors has no effect on xCMRg i u or its variance in the older subjects.
The effect of brain volume on CMRglu has re cently been described by Hatazawa et al. (1987) . Animal studies have shown that there is a gross re lationship between body size and cerebral meta bolic rate (Tower and Young, 1973) , and this rela tionship has been ascribed to differences in neu ronal packing density. Hatazawa et al. (1987) reported a strong relationship between brain volume and xCMRglu values in 23 normal human subjects. It was found in that study, which included 16 men and seven women, that there was a correla tion coefficient of -0.75 between global CMRglu and estimated brain volume, and that this negative correlation was independent of gender, because men alone showed this significant relationship. Our results show a weak but significant relationship be tween brain volume and CMRglu in men and an in significant relationship in women. When data on men and women are combined, our results indicate a significant, although weak, correlation between brain size and CMRglu' Although our findings cor respond to and are in the same direction as those of Hatazawa et al., differences in magnitude of effects may be related to the fact that our estimates of brain volume were based on true area measure ments of the individual brains, from MR scans, rather than the length and breadth of the brain as derived from PET images. In addition, all of our results were obtained on a single PET scanner rather than two different scanners, as reported by Hatazawa. Some previous studies employing CBP measure ments have shown a systematic effect of gender, with women having up to 15-20% higher values than men (Gur et aI., 1982; Devous et aI., 1986; Baxter et aI., 1987) . Brain volume was not mea sured in these studies, and it is likely that these CBP differences could be explained on the basis of brain volume differences between men and women. In the present study the highly significant gender differences in xCMR g lu were eliminated by covary ing for both brain volume and brain atrophy.
In previous investigations, where the physiolog ical conditions of measurement of cerebral glucose metabolism have been well defined and have in cluded relative sensory deprivation, no age-related reduction or only a trend toward reduction of xCMR g 1u has been found (Duara et aI. , 1984; de Leon et aI., 1984; Schlageter et aI. , 1987) . The present results, which indicate a significant reduc tion with age in xCMR g l u, uncorrected for brain at rophy and volume in 76 subjects, and a trend to ward reduction of uncorrected xCMR g 1 u in the 58 subjects who had MR scans, agree very well with previous findings reported. It would appear that the effect of age on xCMR gl u becomes significant only when a large number of subjects is studied. It is clear, however, from the results of this study, that when corrections for brain atrophy and volume are made, xCMR g 1u shows no relation to age. However, it is unknown in the human what impact age has on the lumped constant or the kinetic constants used in the calculation of CMR g1 u' These constants may alter with age and thus have an effect on the abso lute values of CMR g lu (Takei et aI. , 1986; Hawkins et aI. , 1983) .
Correction of CMR g 1u values for the effects of brain atrophy has been determined to be an impor tant methodological consideration in the quantita tion of CMR gl u by PET (Herscovitch et aI. , 1986; Chawluk et aI. , 1987; Schlageter et aI., 1987) . Our results are in accordance with those of Schlageter et ai. (1987) in that atrophy was found to contribute only a small amount to the variance in CMR g 1u in normal subjects. Correlation coefficients of -0. 21 to -0. 25 were obtained (Table 4) for the correlation between brain atrophy and CMR gl u' Purther, when gender, age, and brain volume were included in the analyses (Table 5) , we were unable to demonstrate a significant overall effect of brain atrophy on CMR gl u' Only in the frontal lobes was there a signif icant relationship between brain atrophy and CMR g 1u' Our results suggest that in normal sub jects, brain atrophy associated with aging was the second most important contributor to the variance in CMR gl u, but it has a relatively small effect on the quantitation of CMR g 1u for gray matter structures. However, these results are valid only for PET scanners of equivalent resolution to the one used in this study.
In the study by Dastur et ai. (1963) , cerebrovas cular risk factors were found to accentuate the re duction of CBP with age. Similar findings showing a significant effect of cerebrovascular risk factors in reducing CBP were obtained using the Xe-133 in halation method for measuring CBP, by Meyer et ai. (1978) and Naritomi et ai. (1979) . Both these groups reported, however, that even in the absence of cerebrovascular risk factors there was a reduc tion in CBP with age. On the basis of these findings, it may be expected that CMR g 1u would also be affected by the presence of cerebrovascular risk factors. Normally there is coupling between CBP and CMR g 1u, so that as CBP declines, CMR gl u may also be expected to decline to a proportional extent (Sokoloff, 1978) . In our present study, how ever, we have been unable to show any effect of cerebrovascular risk factors on CMR gl u' Similar re sults, for CMR g 1u, have been reported by Chawluk et ai. (1987) and Dastur et ai. (1963) . As age and cerebrovascular risk factors alter cerebrovascular resistance (Dastur et aI. , 1963) without necessarily producing cerebral ischemia or infarction, CBP may be expected to decline, although the metabolic rate of the cerebral tissue, and therefore the glu cose utilization, could stay unchanged. We believe that our findings are consistent with this hy pothesis, notwithstanding the findings by Dastur et ai. (1963) of reduced CMR g 1u with unchanged CBP in normal elderly subjects compared with normal young subjects.
In conclusion, our results indicate that the vari ability in resting CMR gl u cannot be greatly reduced, either for men or women, by taking into account the above-mentioned factors, because in total they explain only �2 1% of the variance in CMR g 1u' Some reduction in variance may be achieved by conducting studies under conditions of defined be havioral activation rather than in the resting state, as we have previously shown (Duara et aI., 1987) . However, this variability, which currently reduces the usefulness of CMR g lu measures in detecting dis ease, almost certainly has important physiological significance. In addition, it also probably reflects the effects of certain methodological errors in the quantitation of CMRg\u by PET. (These method ological errors include the use of "arterialized" venous blood for measurement of plasma radioac tivity and glucose concentrations, standard kinetic constants kj, k�, kj, and k4 and an operator drawn ellipse for attenuation correction, all of which can be resolved.) On the basis of observations from various behavioral activation studies done in this laboratory (Parks et al., in press; Chang et aI., 1987; Duara et aI., 1987; Ginsberg et aI., 1987) , we venture to speculate that the dominant factor re sponsible for the variance in CMRg\u in humans is the state of behavioral arousal. If a valid index of the relative state of arousal in humans were avail able, this could possibly prove to be the best pre dictor of CMRg\u values.
